Join us at the HCPA XPAND2021 Annual Meeting on December 6-9, 2021 in Fort Lauderdale, Florida. A variety of topics will be discussed: public policy and regulatory issues, product registrations, disruptions caused by COVID-19, and much more. Expert-led sessions, for every division and committee, will be held to discuss issues that impact household and commercial products, including ingredient communication, retailer expectations, product safety, supply chain, market trends, packaging, and technical issues.
Melinda and Jeremy will be available throughout this meeting to meet with you and answer any questions you have regarding our regulatory and technical consultancy services.
CSI has an established reputation in supporting registration of a range of antimicrobial/biocidal products including disinfectants, sterilizers, preservatives, and unique antimicrobial applications. We support clients introducing their products in European and North American markets through cost-effective strategies.
In the US, we help clients with US Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) regulated antimicrobial products, as well as State registration management.
In Europe, we assist with active substance approval and biocidal product authorisations to comply with the requirements for the European Economic Area (EEA) (i.e. EU27 plus Iceland, Liechtenstein and Norway). With the new GB BRP regulation now in force for Great Britain, CSI is able to offer GB Article 95 representative support for EU companies.
We also support the global marketplace and have successfully assisted firms with registrations in Canada, Latin America, Asia (China/Taiwan), Australasia, and other geographical markets.
Experienced Support For:
- Registration Dossier Preparation & Submission
- Regulatory Strategy
- Data Review & Evaluation
- Hazard, Exposure, & Risk Assessments for Human Health & Environment
- Task Force Management
- Litigation Support